Elisabeth Manville
Apr 11, 2012

Researchers identify how human antibodies overcome dengue virus

Through studying humans who have been infected with the dengue virus, scientists have pinpointed the region on the virus that is neutralized in those who beat the infection. This finding could be a significant step in the development of a dengue vaccine. Previously, researchers had relied on mouse studies to understand the virus. By analyzing the blood cells of locals who had contracted the virus on their travels, University of North Carolina researchers found that, unlike in mice, human antibodies that neutralized the virus bound to a complex structure that was only present on a completely assembled dengue virus. “Our study for the first time shows what region the immune system of humans target when they are fighting off the virus, senior study author Aravinda M. de Silva said. “The region on the virus targeted by the human immune system is quite different from the region targeted by mice.”

Companies
1
Patents
1
0 Comments
Related Articles
Alejandro Freixes
Oct 19, 2011
World's first major malaria vaccine works in major trial
  By Kate Kelland and Ben Hirschler SEATTLE/LONDON (Reuters) -An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a... Read More
Elisabeth Manville
Mar 19, 2012
Could Twitter prevent epidemics? Using the Internet to survey public health
Most of us have turned to the Internet when we’ve felt under the weather at one point or another. We... Read More
Angela Hernandez
Apr 5, 2012
Discovery of immune cell response could lead to more effective vaccines
Researchers at the Walter and Eliza Hall Institute have identified how a protein found on the surface of immune cells... Read More